US Food and Drug Administration officials said it approved Skyla a hormone-releasing system in the uterus that prevents pregnancy for up to three years. Dr Anita L. Nelson, a professor of obstetrics and gynecology at Harbor-UCLA Medical Center in Torrance, Calif., said Skyla is a small, flexible plastic T-shaped device by Bayer HealthCare Pharmaceuticals, a Montville, NJ, subsidiary of the German pharmaceutical giant Bayer, that contains 13.5 milligrams of a progestin hormone levonorgestrel. Because Skyla slowly releases levonorgestrel into the uterus, only small amounts of the hormone enter the blood. During the first three to six months of using Skyla, women might experience irregular periods and an increase in the number of bleeding days. Nelson said women might also have frequent spotting or light bleeding, while some women might have heavy bleeding. After using Skyla for a while, the number of bleeding and spotting days is likely to lessen. "Research shows that nearly 50 percent of U.S. pregnancies are unintended, which emphasizes the need for increased education and access to effective birth control options," Nelson said in a statement. "Skyla is more than 99 percent effective at preventing pregnancy and might be appropriate for women who want a birth control method that they do not have to take daily." Women can have Skyla placed by a healthcare provider during an in-office visit for up to three years but may be removed by a healthcare provider at any time, Nelson said. Skyla -- levonorgestrel-releasing intrauterine system -- will be available by prescription the week of Feb. 11, Bayer officials said.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor